Wealth Effects’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
PCM
AAM
Wealth Effects's ECAT Position: Q2 2026 in Review
Wealth Effects reduced its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 1.9% in Q2 2026, selling an estimated $11.1K and leaving 37,577 shares worth $591K. The position accounts for 0.16% of the portfolio, ranked #116.
Wealth Effects first reported a position in ECAT in Q1 2026 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold ECAT as of Q2 2026.
- Wealth Effects held 37,577 shares of BlackRock ESG Capital Allocation Term Trust worth $591K as of Q2 2026.
- Wealth Effects sold 733 BlackRock ESG Capital Allocation Term Trust shares in Q2 2026, an estimated $11.1K.
- BlackRock ESG Capital Allocation Term Trust made up 0.16% of Wealth Effects's portfolio in Q2 2026, its #116 holding.
- Wealth Effects first reported a position in BlackRock ESG Capital Allocation Term Trust in Q1 2026 and has held it in 2 quarters since.
- 79 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2026.
Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.